The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin
Abstract
The anticancer drugs adriamycin and daunomycin have each been crystallized with the DNA sequence d(CGATCG) and the three-dimensional structures of the complexes solved at 1.7- and 1.5-A resolution, respectively. These antitumor drugs have significantly different clinical properties, yet they differ chemically by only the additional hydroxyl at C14 of adriamycin. In these complexes the chromophore is intercalated at the CpG steps at either end of the DNA helix with the amino sugar extended into the minor groove. Solution of the structure of daunomycin bound to d(CGATCG) has made it possible to compare it with the previously reported structure of daunomycin bound to d(CGTACG). Although the two daunomycin complexes are similar, there is an interesting sequence dependence of the binding of the amino sugar to the A-T base pair outside the intercalation site. The complex of daunomycin with d(CGATCG) has tighter binding than the complex with d(CGTACG), leading us to infer a sequence preference in the binding of this anthracycline drug. The structures of daunomycin and adriamycin with d(CGATCG) are very similar. However, there are additional solvent interactions with the adriamycin C14 hydroxyl linking it to the DNA. Surprisingly, under the influence of the altered solvation, there is considerable difference in the conformation of spermine in these two complexes. The observed changes in the overall structures of the ternary complexes amplify the small chemical differences between these two antibiotics and provide a possible explanation for the significantly different clinical activities of these important drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular structure of a left-handed double helical DNA fragment at atomic resolution
Wang, A. H.-J., Quigley, G. J., Kolpak, F. J., Crawford, J. L., van Boom, J. H., van der Marel, G., & Rich, A. (1979) · Nature · doi:10.1038/282680a0 · Cited by 2,118
Self-citationStructure of a B-DNA dodecamer
Drew, H. R., & Dickerson, R. E. (1981) · Journal of Molecular Biology · doi:10.1016/0022-2836(81)90009-7 · Cited by 918
Crystal structure analysis of a complete turn of B-DNA
Wing, R., Drew, H., Takano, T., Broka, C., Tanaka, S., Itakura, K., & Dickerson, R. E. (1980) · Nature · doi:10.1038/287755a0 · Cited by 872
DNA conformation is determined by economics in the hydration of phosphate groups
Saenger, W., Hunter, W. N., & Kennard, O. (1986) · Nature · doi:10.1038/324385a0 · Cited by 448
Wang, A. H. J., Ughetto, G., Quigley, G. J., & Rich, A. (1987) · Biochemistry · doi:10.1021/bi00378a025 · Cited by 405
Self-citationMolecular structure of an anticancer drug-DNA complex: daunomycin plus d(CpGpTpApCpG).
Quigley, G. J., Wang, A. H., Ughetto, G., van der Marel, G., van Boom, J. H., & Rich, A. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7204 · Cited by 362
Self-citationStereochemistry of Intercalation: Interaction of Daunomycin with DNA
PIGRAM, W. J., FULLER, W., & HAMILTON, L. D. (1972) · Nature New Biology · doi:10.1038/newbio235017a0 · Cited by 358
Definitions and nomenclature of nucleic acid structure components
Dickerson, R. E. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.5.1797 · Cited by 271
Coll, M., Aymami, J., Van der Marel, G. A., Van Boom, J. H., Rich, A., & Wang, A. H. J. (1989) · Biochemistry · doi:10.1021/bi00427a042 · Cited by 213
Self-citationSequence-dependent conformation of an A-DNA double helix
Shakked, Z., Rabinovich, D., Kennard, O., Cruse, W. B. T., Salisbury, S. A., & Viswamitra, M. A. (1983) · Journal of Molecular Biology · doi:10.1016/s0022-2836(83)80005-9 · Cited by 210
Cited by
RNA phase transitions in repeat expansion disorders
(2017) · doi:10.1038/nature22386 · Cited by 911
Rawat, P. S., Jaiswal, A., Khurana, A., Bhatti, J. S., & Navik, U. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111708 · Cited by 909
Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy
Yu, M. K., Park, J., & Jon, S. (2012) · Theranostics · doi:10.7150/thno.3463 · Cited by 883
An Aptamer–Doxorubicin Physical Conjugate as a Novel Targeted Drug‐Delivery Platform
Bagalkot, V., Farokhzad, O. C., Langer, R., & Jon, S. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200602251 · Cited by 613
DNA Origami Delivery System for Cancer Therapy with Tunable Release Properties
Zhao, Y.-X., Shaw, A., Zeng, X., Benson, E., Nyström, A. M., & Högberg, B. (2012) · ACS Nano · doi:10.1021/nn3022662 · Cited by 519
Topoisomerases as anticancer targets
Delgado, J. L., Hsieh, C.-M., Chan, N.-L., & Hiasa, H. (2018) · Biochemical Journal · doi:10.1042/bcj20160583 · Cited by 481
Anthraquinones As Pharmacological Tools and Drugs
Malik, E. M., & Müller, C. E. (2016) · Medicinal Research Reviews · doi:10.1002/med.21391 · Cited by 448
Pang, B., Qiao, X., Janssen, L., Velds, A., Groothuis, T., Kerkhoven, R., Nieuwland, M., Ovaa, H., Rottenberg, S., van Tellingen, O., et al. (2013) · Nature Communications · doi:10.1038/ncomms2921 · Cited by 420
The B-DNA Dodecamer at High Resolution Reveals a Spine of Water on Sodium,
Shui, X., McFail-Isom, L., Hu, G. G., & Williams, L. D. (1998) · Biochemistry · doi:10.1021/bi973073c · Cited by 404
Self-citationCalorimetry and Thermodynamics in Drug Design
Chaires, J. B. (2008) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.36.040306.132812 · Cited by 389
Sp1 transcription factor: A long-standing target in cancer chemotherapy
Vizcaíno, C., Mansilla, S., & Portugal, J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.008 · Cited by 377
Mohan, P., & Rapoport, N. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100269f · Cited by 331
Hannon, M. J. (2007) · Pure and Applied Chemistry · doi:10.1351/pac200779122243 · Cited by 313
Prakash, S., Malhotra, M., Shao, W., Tomaro-Duchesneau, C., & Abbasi, S. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.013 · Cited by 256
Li, Y., Liu, G., Ma, J., Lin, J., Lin, H., Su, G., Chen, D., Ye, S., Chen, X., Zhu, X., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.05.011 · Cited by 255
Hoepfner, D., Helliwell, S. B., Sadlish, H., Schuierer, S., Filipuzzi, I., Brachat, S., Bhullar, B., Plikat, U., Abraham, Y., Altorfer, M., et al. (2014) · Microbiological Research · doi:10.1016/j.micres.2013.11.004 · Cited by 166
Tetracenomycin X inhibits translation by binding within the ribosomal exit tunnel
Osterman, I. A., Wieland, M., Maviza, T. P., Lashkevich, K. A., Lukianov, D. A., Komarova, E. S., Zakalyukina, Y. V., Buschauer, R., Shiriaev, D. I., Leyn, S. A., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0578-x · Cited by 75
Tippin, D. B., & Sundaralingam, M. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.0945 · Cited by 42
Mishra, N., Tiwari, V. K., & Schmidt, R. R. (2020) · Carbohydrates in Drug Discovery and Development · doi:10.1016/b978-0-12-816675-8.00001-4 · Cited by 17
Metadata
- Authors
- Frederick, C. A., Williams, L. D., Ughetto, G., Van der Marel, G. A., Van Boom, J. H., Rich, A., & Wang, A. H. J.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1990-03-01
- Volume
- 29
- Issue
- 10
- Pages
- 2538-2549
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2162417581
- Cited by
- 578
- References
- 19
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.